This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
frequency of persistent partially clipped or unclipped aneurysms, morbidity rate associated with angiography, combined morbidity and mortality rate associated with early/late subsequent haemorrhage, rate of early subsequent haemorrhage, unclipped aneurysm, annual rate of late subsequent haemorrhage, unclipped aneurysm/partially clipped aneurysm.
Study designs and other criteria for inclusion in the review
The criteria for inclusion in the review were not stated. Prospective studies and case series were among the studies referenced.
Sources searched to identify primary studies
Not reported.
Criteria used to ensure the validity of primary studies
Not stated.
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
A total of 10 studies were directly used as the references for the transition probabilities, and 8 further studies were referenced indirectly.
Methods of combining primary studies
The narrative method was used to obtain initial input data (mostly from recent studies).
Investigation of differences between primary studies
Not performed.
Results of the review
Baseline values were as follows: frequency of unexpected partially clipped/unclipped aneurysms, 4%, combined morbidity and mortality rate associated with subsequent surgery, 12%, frequency of persistent partially clipped or unclipped aneurysms, 12%, morbidity rate associated with angiography, 0.5%, combined morbidity and mortality rate associated with early subsequent haemorrhage, 80% and late subsequent haemorrhage, 50%, rate of early subsequent haemorrhage, unclipped aneurysm, 40%, Incremental cost-utility (cost per additional QALY gained) was calculated as a measure of cost-utility. Using baseline values, routine postoperative angiography resulted in an acceptable cost-utility ratio of $22,500/QALY. However, the vast majority of the added benefits resulted from intervention on unexpected unclipped aneurysms; conversely, intervention on unexpected partially clipped aneurysms was not cost-effective. The acceptable cost for this analysis was considered to be less than $50,000 per additional QALY. Sensitivity analyses showed that the cost of angiography had a moderate influence on the cost-utility analysis, while small alterations in surgical complication rates resulted in marked changes in the cost-utility ratio in the setting of partially clipped aneurysms.
Authors' conclusions
When routine postsurgical angiography was performed primarily to diagnose and subsequently to operate on unexpected partially clipped aneurysms, the cost-benefit ratio was unacceptable. However, even low frequencies of unexpected unclipped aneurysms resulted in favourable cost-benefit ratios.
CRD COMMENTARY -Selection of comparators
The reason for the choice of the comparator is clear.
Validity of estimate of measure of benefit
The internal validity of the estimates of benefit (baseline values) can not be reasonably guaranteed given the apparent lack of a systematic literature review and quality assessment of the primary studies included in the review. There was also a lack of adequate information on the methods used to derive utility factors attributed to different health states. Some benefit components (such as mass effect from regrowth to giant sizes of aneurysm rests) as well as the effects of co-morbid disease were not included in the analysis, (as mentioned by the authors).
Validity of estimate of costs
Quantities and costs were not presented separately and insufficient details of methods of cost estimation were given. Although the authors stated that the cost analysis was carried out from a societal perspective, indirect costs, such as lost wages, were not included (the authors gave some explanations in this regard).
Other issues
The authors' conclusion seems reasonably justifiable given the extensive sensitivity analyses performed. The authors acknowledged that their results could not be applied in the following cases:
(1) when a suboptimal result is expected after postoperative angiography;
(2) intraoperative angiography (repositioning aneurysm clips intraoperatively); (3) in individual cases, because of expected wide variation among patients (it should be interpreted in the context of decisions regarding the application of routine postoperative angiography in general).
Appropriate comparisons were made with other studies.
Implications of the study
Refined data regarding the frequency of unexpected unclipped aneurysms would be highly valuable, since unclipped aneurysms had a marked effect on the cost-benefit ratios.
